oyikey smgt glp 1 Oyikey™ SMGT-GLP-1 Nano Microneedle Patch Oyikey SMGT-GLP-1 Nano Microneedle Patch,SMGT-GLP-1
Description
If you are part of the roughly 12 percent of adults in the United States currently taking a GLP-1 medication for weight loss or to manage your type 2 diabetes
Our new whitepaper combines data from the QYOBO Platform - prices, API manufacturers, compliance signals - with commentary from Thomas Tong, CEO of Sinopep-Allsino Biopharmaceutical Co., Ltd., the leading API manufacturer in this space
Oikos Fusion
Click on the arrows at the top of each section to read more
Approximately half of those (N=7,256) had ASCVD and obesity without diabetes mellitus (3.16% of ASCVD patients)
